Betting on a new Cancer Drug
Kevin Williams had taken the breakthrough cancer drug Gleevec for more than two years, but the medicine made little headway against the leukemia ravaging his blood and its side effects sapped his
Kevin Williams had taken the breakthrough cancer drug Gleevec for more than two years, but the medicine made little headway against the leukemia ravaging his blood and its side effects sapped his